Congenital long QT syndrome

Michael John Ackerman, Anant Khositseth, David J. Tester, Peter J. Schwartz

Research output: Chapter in Book/Report/Conference proceedingChapter

10 Citations (Scopus)

Abstract

Once considered an extremely rare yet lethal arrhythmogenic peculiarity, congenital long QT syndrome (LQTS) is understood today as a primary cardiac arrhythmia syndrome (cardiac channelopathy) that is both far more common and, overall, much less lethal than previously recognized. Clinically, LQTS is often characterized by prolongation of the heart rate corrected QT interval (QTc) on a 12-lead surface electrocardiogram (ECG) and is associated with syncope, seizures, and sudden cardiac death due to ventricular arrhythmias (Torsade des pointes, TdP) usually following a precipitating event such as exertion, extreme emotion, or auditory stimulation. The molecular breakthroughs of the 1990s, led in large measure by the research laboratories of Drs. Mark Keating and Jeffrey Towbin in conjunction with LQTS registries containing meticulously phenotyped patients directed by Drs. Arthur Moss and Peter Schwartz, revealed the fundamental molecular underpinnings of LQTS- namely, defective cardiac channels.1

Original languageEnglish (US)
Title of host publicationElectrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention
PublisherSpringer London
Pages462-482
Number of pages21
ISBN (Print)9781846288531
DOIs
StatePublished - 2008

Fingerprint

Long QT Syndrome
Cardiac Arrhythmias
Channelopathies
Bryophyta
Acoustic Stimulation
Sudden Cardiac Death
Syncope
Registries
Electrocardiography
Emotions
Seizures
Heart Rate
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ackerman, M. J., Khositseth, A., Tester, D. J., & Schwartz, P. J. (2008). Congenital long QT syndrome. In Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention (pp. 462-482). Springer London. https://doi.org/10.1007/978-1-84628-854-8_33

Congenital long QT syndrome. / Ackerman, Michael John; Khositseth, Anant; Tester, David J.; Schwartz, Peter J.

Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention. Springer London, 2008. p. 462-482.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ackerman, MJ, Khositseth, A, Tester, DJ & Schwartz, PJ 2008, Congenital long QT syndrome. in Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention. Springer London, pp. 462-482. https://doi.org/10.1007/978-1-84628-854-8_33
Ackerman MJ, Khositseth A, Tester DJ, Schwartz PJ. Congenital long QT syndrome. In Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention. Springer London. 2008. p. 462-482 https://doi.org/10.1007/978-1-84628-854-8_33
Ackerman, Michael John ; Khositseth, Anant ; Tester, David J. ; Schwartz, Peter J. / Congenital long QT syndrome. Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention. Springer London, 2008. pp. 462-482
@inbook{60b6806e6a9b4949843a4ea6ffc40d26,
title = "Congenital long QT syndrome",
abstract = "Once considered an extremely rare yet lethal arrhythmogenic peculiarity, congenital long QT syndrome (LQTS) is understood today as a primary cardiac arrhythmia syndrome (cardiac channelopathy) that is both far more common and, overall, much less lethal than previously recognized. Clinically, LQTS is often characterized by prolongation of the heart rate corrected QT interval (QTc) on a 12-lead surface electrocardiogram (ECG) and is associated with syncope, seizures, and sudden cardiac death due to ventricular arrhythmias (Torsade des pointes, TdP) usually following a precipitating event such as exertion, extreme emotion, or auditory stimulation. The molecular breakthroughs of the 1990s, led in large measure by the research laboratories of Drs. Mark Keating and Jeffrey Towbin in conjunction with LQTS registries containing meticulously phenotyped patients directed by Drs. Arthur Moss and Peter Schwartz, revealed the fundamental molecular underpinnings of LQTS- namely, defective cardiac channels.1",
author = "Ackerman, {Michael John} and Anant Khositseth and Tester, {David J.} and Schwartz, {Peter J.}",
year = "2008",
doi = "10.1007/978-1-84628-854-8_33",
language = "English (US)",
isbn = "9781846288531",
pages = "462--482",
booktitle = "Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention",
publisher = "Springer London",

}

TY - CHAP

T1 - Congenital long QT syndrome

AU - Ackerman, Michael John

AU - Khositseth, Anant

AU - Tester, David J.

AU - Schwartz, Peter J.

PY - 2008

Y1 - 2008

N2 - Once considered an extremely rare yet lethal arrhythmogenic peculiarity, congenital long QT syndrome (LQTS) is understood today as a primary cardiac arrhythmia syndrome (cardiac channelopathy) that is both far more common and, overall, much less lethal than previously recognized. Clinically, LQTS is often characterized by prolongation of the heart rate corrected QT interval (QTc) on a 12-lead surface electrocardiogram (ECG) and is associated with syncope, seizures, and sudden cardiac death due to ventricular arrhythmias (Torsade des pointes, TdP) usually following a precipitating event such as exertion, extreme emotion, or auditory stimulation. The molecular breakthroughs of the 1990s, led in large measure by the research laboratories of Drs. Mark Keating and Jeffrey Towbin in conjunction with LQTS registries containing meticulously phenotyped patients directed by Drs. Arthur Moss and Peter Schwartz, revealed the fundamental molecular underpinnings of LQTS- namely, defective cardiac channels.1

AB - Once considered an extremely rare yet lethal arrhythmogenic peculiarity, congenital long QT syndrome (LQTS) is understood today as a primary cardiac arrhythmia syndrome (cardiac channelopathy) that is both far more common and, overall, much less lethal than previously recognized. Clinically, LQTS is often characterized by prolongation of the heart rate corrected QT interval (QTc) on a 12-lead surface electrocardiogram (ECG) and is associated with syncope, seizures, and sudden cardiac death due to ventricular arrhythmias (Torsade des pointes, TdP) usually following a precipitating event such as exertion, extreme emotion, or auditory stimulation. The molecular breakthroughs of the 1990s, led in large measure by the research laboratories of Drs. Mark Keating and Jeffrey Towbin in conjunction with LQTS registries containing meticulously phenotyped patients directed by Drs. Arthur Moss and Peter Schwartz, revealed the fundamental molecular underpinnings of LQTS- namely, defective cardiac channels.1

UR - http://www.scopus.com/inward/record.url?scp=84890172651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890172651&partnerID=8YFLogxK

U2 - 10.1007/978-1-84628-854-8_33

DO - 10.1007/978-1-84628-854-8_33

M3 - Chapter

AN - SCOPUS:84890172651

SN - 9781846288531

SP - 462

EP - 482

BT - Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention

PB - Springer London

ER -